BNB Plus Corp.
0.08
EUR
+0.05
(+155.00%)
BNB Plus Corp.
GETTEX:UDJ1
(Gettex)
Recent
price
0.08
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- BNB Plus Corp., formerly known as Applied DNA Sciences, Inc., is a biotechnology and digital asset treasury company that develops proprietary enzymatic nucleic acid production platforms and manages a cryptocurrency treasury focused on the Binance (BNB) ecosystem. The company operates through two principal business segments: Biotechnology and Digital Asset Treasury Management. In its biotechnology operations, conducted primarily through its majority-owned subsidiary LineaRx, Inc., the company manufactures and provides linear DNA and RNA production technologies, including: LineaDNA, a proprietary cell-free, polymerase chain reaction (PCR)-based DNA manufacturing platform serving as an enzymatic alternative to plasmid DNA for use in cell and gene therapies, DNA vaccines, and molecular diagnostics; LineaIVT, an in vitro transcription platform integrating linear DNA templates with proprietary LineaRNAP RNA polymerase to streamline messenger RNA (mRNA) production and mitigate double-stranded RNA contamination; and CertainT, a supply chain traceability and authentication platform utilizing molecular DNA tags to enable the tracking, testing, and authentication of raw materials and finished goods across industrial textiles, synthetics, and pharmaceuticals. In its digital asset segment, the company implements a corporate treasury strategy focused on the acquisition, holding, and staking of BNB tokens to generate yield and optimize capital efficiency. The company serves biopharmaceutical developers, diagnostic manufacturers, industrial supply chain enterprises, and commercial brands across North America, Europe, and Asia. In major recent corporate developments, the company completed a strategic pivot to integrate a Digital Asset Treasury model, officially changed its corporate name from Applied DNA Sciences, Inc. to BNB Plus Corp. in late 2025, changed its ticker symbol from APDN to BNBX, and transitioned its public stock quotation from the Nasdaq Capital Market to the OTCQB Venture Market in July 2026. BNB Plus Corp. was founded in 1983 and is headquartered in Stony Brook, New York.